Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.

Pollak MR, Brown EM, Chou YH, Hebert SC, Marx SJ, Steinmann B, Levi T, Seidman CE, Seidman JG.

Cell. 1993 Dec 31;75(7):1297-303.

PMID:
7916660
3.

Cloning and functional characterization of extracellular Ca(2+)-sensing receptors from parathyroid and kidney.

Brown EM, Pollak M, Chou YH, Seidman CE, Seidman JG, Hebert SC.

Bone. 1995 Aug;17(2 Suppl):7S-11S. Review.

PMID:
8579901
4.

Impaired cotranslational processing of the calcium-sensing receptor due to signal peptide missense mutations in familial hypocalciuric hypercalcemia.

Pidasheva S, Canaff L, Simonds WF, Marx SJ, Hendy GN.

Hum Mol Genet. 2005 Jun 15;14(12):1679-90. Epub 2005 May 6.

PMID:
15879434
5.
6.
7.
8.

Familial hypocalciuric hypercalcemia caused by an R648stop mutation in the calcium-sensing receptor gene.

Yamauchi M, Sugimoto T, Yamaguchi T, Yano S, Wang J, Bai M, Brown EM, Chihara K.

J Bone Miner Res. 2002 Dec;17(12):2174-82.

10.

The cloning of extracellular Ca(2+)-sensing receptors from parathyroid and kidney: molecular mechanisms of extracellular Ca(2+)-sensing.

Brown EM, Pollak M, Chou YH, Seidman CE, Seidman JG, Hebert SC.

J Nutr. 1995 Jul;125(7 Suppl):1965S-1970S. Review.

PMID:
7602378
11.
12.

Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism associated with mutations in the human Ca2+-sensing receptor gene in three Danish families.

Schwarz P, Larsen NE, Lønborg Friis IM, Lillquist K, Brown EM, Gammeltoft S.

Scand J Clin Lab Invest. 2000 May;60(3):221-7.

PMID:
10885494
13.

Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism.

Pearce SH, Trump D, Wooding C, Besser GM, Chew SL, Grant DB, Heath DA, Hughes IA, Paterson CR, Whyte MP, et al.

J Clin Invest. 1995 Dec;96(6):2683-92.

14.

The pathophysiology of primary hyperparathyroidism.

Brown EM.

J Bone Miner Res. 2002 Nov;17 Suppl 2:N24-9. Review.

PMID:
12412774
15.

Identification of a novel calcium-sensing receptor gene mutation causing familial hypocalciuric hypercalcemia by single-strand conformation polymorphism analysis.

Felderbauer P, Hoffmann P, Klein W, Bulut K, Ansorge N, Epplen JT, Schmitz F, Schmidt WE.

Exp Clin Endocrinol Diabetes. 2005 Jan;113(1):31-4.

PMID:
15662592
16.

New mutation in the CASR gene in a family with familial hypocalciuric hypercalcemia (FHH) and neonatal severe hyperparathyroidism (NSHPT).

Rodrigues LS, Cáu AC, Bussmann LZ, Bastida G, Brunetto OH, Corrêa PH, Martin RM.

Arq Bras Endocrinol Metabol. 2011 Feb;55(1):67-71.

17.

Molecular biology and clinical importance of the Ca(2+)-sensing receptor.

De Luca F, Baron J.

Curr Opin Pediatr. 1998 Aug;10(4):435-40. Review.

PMID:
9757371
18.
19.

The calcium-sensing receptor (CaR) permits Ca2+ to function as a versatile extracellular first messenger.

Brown EM, Chattopadhyay N, Vassilev PM, Hebert SC.

Recent Prog Horm Res. 1998;53:257-80; discussion 280-1. Review.

PMID:
9769711
20.

Familial hypocalciuric hypercalcemia and other disorders with resistance to extracellular calcium.

Brown EM.

Endocrinol Metab Clin North Am. 2000 Sep;29(3):503-22. Review.

PMID:
11033758

Supplemental Content

Support Center